Avelumab

BAVENCIO®

Overview

Avelumab is a monoclonal antibody that targets the programmed death-lignad 1 (PDL1) protein.

SparkCures ID 343
Brand Name Bavencio®
Generic Name Avelumab
Treatment Classifications
Treatment Targets

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.